Peer Review History
| Original SubmissionFebruary 17, 2022 |
|---|
|
PONE-D-22-04580CRISPR/Cas9-Mediated Genomic Knock out of Tyrosine Hydroxylase and Yellow genes in Cricket Gryllus bimaculatusPLOS ONE Dear Dr. He, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Your manuscript was reviewed by three experts. They found that it is preliminary and requires a major revision(s) including additional experiments. I share their recommendations. Please revise it according to their suggestions and perform additional experiments as they suggested. Please submit your revised manuscript by May 07 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Hodaka Fujii, M.D., Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Acknowledgments Section of your manuscript: [This research was funded by the National Natural Science Foundation of China (No. 31801997) and the Natural Science Foundation of Shanghai (19ZR1416100). We also gratefully thank Dr. Hun-Lun Bi and Xia Xu for providing constructive comments on the manuscript.] We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: [National Natural Science Foundation of China (No. 31801997) Natural Science Foundation of Shanghai (19ZR1416100) NO - Include this sentence at the end of your statement: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.] Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.
In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions. 4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ. 5. Please ensure that you refer to Figures 6, 7 and 8 in your text as, if accepted, production will need this reference to link the reader to the figures. 6. Please include captions for figures 6, 7 and 8. 7. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 3 in your text; if accepted, production will need this reference to link the reader to the Table. Additional Editor Comments: Please correct the following wordings: Abstract, p. 2, line 28: "an efficient transient CRISPR/Cas9 system" to "an efficient transient CRISPR/Cas9 expression system" Results, p. 8, line 166: "Fig 2" might be a mistake. Please cite a correct figure. Results, p. 9, line 179: "Fig 3" might be a mistake. Please cite a correct figure. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A Reviewer #3: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No Reviewer #3: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for giving me the opportunity to review “CRISPR/Cas9-Mediated Genomic Knock out of Tyrosine Hydroxylase and Yellow genes in Cricket Gryllus bimaculatus” by Bai et al. In this manuscript, the authors attempted genome editing using CRISPR/Cas9 system into the cricket, Gryllus bimaculatus. Then, they have successfully inducing gene knock-out mutation against TH and yellow-y genes. This genome editing method will not only benefit the cricket research community but will also be important in studies among insect species, especially for researchers who use hemimetabola insects. However, while some potentially interesting results have been observed in this study, there are some concerns. The conclusion of this manuscript is that established the genome modification in G. bimaculatus. But it limits the novelty of this study because of already been published in other groups. Therefore, if the authors more emphasize the functions of melanin pigmentation-related genes, it will be more attractive to broad readers. This is because, from this reviewer's knowledge, findings from studies on the function of cuticular coloration in hemimetabola insects, including cricket, are not fully understood. Major concerns: The text is organized but there is missing information and thus the data should be incorporated in the manuscript with referred following comments. The main concern to this manuscript is that the authors did not focus on expression levels of TH and yellow-y genes between wt and those mutants. Therefore, it is hard to understand the mutant phenotypes are due to null or hypomorphic mutations. It should be shown that the expression level of TH and yellow-y genes were decreased or not on the mutant by (semi-) quantitative PCR. Otherwise, at least it should be compared the phenotypes by those RNAi mutants. Line 176 at the section of Phenotypic analysis: Please more describe details in TH and yellow-y mutants with showing dissected parts or with enlargement of the figure for the parts. In holometabola insects, the cuticular coloration pattern differs among tissues (i.e., the compound eye and the majority of body cuticles). These phenotypic differences could be observed in results (Fig. 3 and Fig. 4). Is there any evidence the Gryllus yellow-y used in this experiment is certainly the gene classified in yellow-y among insects, beyond the blast search? Please take considering phylogenetic analysis using Yellow family proteins among insects including Gryllus yellow genes. The melanization in insect pigmentation undergoes enzymatic cascades. It is possible that mutants with weakened enzymatic activity may be slower than normal in coloration. Please show the time course changes in body coloration of the wild type and the mutant during development. Please prepare the table having injection statistical numbers. The table should have at least numbers of Injected eggs, Hatched nymphs, Visible mosaic adults. Adding for yellow-y, it should have the number of F0 adults crossed and F1 with color mutation. Minor concerns: Fig. 1 and 2, It is hard to understand where gRNA is bound in present figures in which the sequences were shown by amino acids. It should be shown gRNA location with the sequence of nucleic acids. Fig. 1 and 2, Is there any functional domain in those genes? Please show overlaying the domains into current figures. Line 105, Please describe what type of PCR enzyme was used for producing gRNA in this experiment. Lin 219, Please use Holometabola and Hemimetabola to specify the metamorphic type. Figure 3, Please center the PAM sequence in the sequence wave. This will give information on the mutation status of the surrounding 5’ and 3’ sequences. Reviewer #2: The manuscript by Yun Bai et al., entitled “CRISPR/Cas9-Mediated Genomic Knock out of Tyrosine Hydroxylase and Yellow genes in Cricket Gryllus bimaculatus”, addresses the methods of gene knock-out using CRISPR/Cas9 system, targeting two pigmentation genes TH and yellow-y. The Authors obtained TH knock-out F0, and yellow-y knock-out F0 and F1, using single gRNA and Cas9 protein, and showed their edited sequences and pigmentation defect phenotypes. In Gryllus bimaculatus, gene knock-out and targeted gene insertion mediated by gRNA and Cas9 mRNA are established. The authors claimed that genome editing using Cas9 protein is the preferred choice in Gryllus bimaculatus, like in Pyrrhocoris apterus, based on their results. However, genome editing method using Cas9 protein in G. bimaculatus is already established (Ohde et al., 2022), and authors did not fully perform to confirm their genome editing results. Thus, the novelty of their findings is quite limited. Major comments In figure 1, genome structures of TH and yellow-y genes are incorrect. TH gene (BAM15632.1) and yellow-y gene (GBI_10058-RA) contain at least 11 and 4 exons, respectively, in G. bimaculatus genome. Line 166 and Figure 2A,B. The authors briefly describe the results of in vitro Cas9 cleavage assay, but the authors should describe their results more carefully. There are no information about the size of DNA marker. In figure 2A, the amounts of DNA samples are different in each lane; the amounts of DNA in lanes 2 and 3 looks much larger than in lanes 3 and 4. I think Cas9 cleavage assay should be done to same amount of DNA. In figure 2B, band patterns of lanes 2-7 were faint and out-of-focus, thus, it was difficult to distinguish the cleavage pattern. The authors should perform in vitro cleavage assay using same amounts of DNA fragments and show the lengths of DNA fragments or DNA marker. lines 173-175. The authors claimed that DNA sequences of injected group showed multiple peaks, in figure 2B and C. The authors showed WT and TH in complimentary, but should show normal directions. The authors need to add the explanation about the red rectangles (maybe those indicate PAM sequences?). About the phenotypic analysis. The authors showed TH and yellow-y knocking-out F0 nymphs in figure 3. In my knowledge, cricket exoskeleton is formed several layers and some layers accumulate melanin pigment, but other layers does not. The authors focused on the pigmentation genes functions in this paper, the authors should show the pigmentation defects in the exoskeleton by sectioning WT and injected F0 nymphs. Such experiments would provide the data related to the mosaicism of genome editing F0 nymphs using CRISPR/Cas9 system. After melanin synthesis gene knocking-out, however, crickets showed brownish body color. The authors should show the results, or discuss, about other pigments, especially about ommochromes, which appears brownish or reddish color. The authors claimed that most of TH genome editing F0 nymphs died before or during the first molting, but the authors did not mention about the reasons of their nymphal lethal phenotype. TH catalyses tyrosine to dopa, and dopa is not a substrate of melanin but also dopamine. I recommend that the authors should detect and compare the amount of dopamine in WT and TH genome editing nymphs, because dopamin is involved neuronal activeties. The authors showed the photos of TH or yellow-y genome editing nymphs that appear mosaicisms in figure 3, and the authors determined the specific mutation types from these genome editing nymphs and showed the sequences in figure 5. However, the authors did not specify which sequences were obtained from which CRISPANTs. In figure 5, some sequences have 3, 6, 21 bp deletion or 9 bp insertion that leads in-frame mutation, thus, mutated TH or yellow-y protein have 1, 2, 7 amino acids deletion or 3 amino acids insertion. Generally, these small in-frame deletion or insertion may not affect an enzymatic activity. In figure 5A, TH genome editing nymph in the most left panel shows blackish pigment pattern, similar to the WT or Control, speculating that these blackish nymphs have in-frame mutation. The authors should carefully show the relationship between mutation patterns of TH and yellow-y genes and mutant phenotypes of pigmentation. In Table 2 and Figure 5B, the authors showed phenotypes of yellow-y / WT F1 nymphs. The authors showed a ratio of mutant and WT as nearly 50% and 50% in both yellow-y male / WT female and yellow-y female / WT male. Is this ratios mean that genetic locus of yellow-y is on autosome, not on a sex chromosome? The authors should discuss about the ratio of F1 generation. In figure 5D, the authors showed DNA sequencing results of TH and yellow-y genome editing eggs and WT. Again, the authors showed the sequences of yellow-y in complementary, but should be shown in normal direction. In the figure legends, the authors wrote that the red rectangles in the figure are the PAM sequences. In figure 5D, four letters CTCG in TH and GGTG in yellow-y were boxed in red rectangles, but the PAM sequences of Cas9 is three letters (NGG), not four letters. The authors should show the correct PAM sequences. In general, expressions of the genome-edited genes (in this case, TH and yellow-y) of CRISPANTs and WT should be determined and compared in mRNA level and protein level, by using qPCR (or northern blot) and Western blot, in addition to the determination of DNA sequencing of targeted sites. As the author mentioned in Discussion section, the authors should determine whether mutations occur in off-targets or not. Minor comments line 66 (so called "insertions") should be (so called "indels"). Line 122 "The vitro" should be "The in vitro". Line 150 "TM" in "AxyPrep TM Multisource Genomic DNA Minipres Kit" should be in superscript. Line 269 "Lim, K.-T.J.P.o." should be "Lim, K.-T.". Line 282 ""Noji, S.J.S." should be "Noji, S.". Line 295 The authors names and journal name are incorrect. Lines 351-354 The authors names are incorrect. Line 388 and 389-390 G. bimaculatus should be in italic. Line 388 and 390 "5nd" should be "5th". Line 395 "8nd" should be "8th". Reviewer #3: In this paper, the authors examine function of TH and yellow genes in a model insect species, Gryllus bimaculatus, in the melanin pathway. They use CRISPR to target these genes and demonstrate mutant phenotypes. The results suggest that the mutagenesis using Cas9 protein rather than Cas9 mRNA is feasible for this species, and that mutagenesis for both TH and yellow genes causes body color chages in nymphs. The conculsion of this paper seems reasonable; however, the data presented in this study are rather preliminary and I have concerns about the quality of the data presented in the paper and the description of the results. Overall, I feel that the paper is too preliminary to be considered for publication. Major comments: 1) Although this paper emphasizes the success of mutagenesis using the Cas9 protein as an achievement, the use of the Cas9 protein is already a widely known method and is not novel, even if it is the first report of its use in crickets. Even leaving novelty aside, if the efficacy of Cas9 protein is to be emphasized, at least comparative data with the use of mRNA against the same target are needed. 2) Result page9:It is not appropriate to argue the function of TH from the phenotype at F0 described in this paper. There is a lack of analytical data on the phenotype (e.g., effect on cuticle thickness). In particular, although it is reasonable to assume that the lack of dopamine synthesis does indeed affect body color, it is difficult to determine from the results obtained whether this is a systemic or localized function. Although it is stated that most TH knockouts are lethal, not all, and it is considered possible to obtain the next generation by reducing the amount of Cas9 introduced, etc. TH gene function should be considered based on the phenotype of the heterozygous or homozygous knockout. 3) Line 183, Fig.4: The F1 phenotype of the Yellow gene knockout is described as brown or black body color. However, the correspondence between the described phenotype and genotype is unclear in the paper. It is essential to clarify the exact correspondence with the genotype in order to infer the gene function from the phenotype of the mutant. 4) The insect yellow gene family generally contains a large number of genes (as the authors also state in line 231 of the text). More detailed verification and description of which genes of the gene family have been knocked out is needed to reach the conclusions of this paper. Can the gene targeted by the authors be considered a true ortholog of the Drosophila yellow gene? The specificity of genome editing must also be verified, as genes of the same family are likely to have similar nucleotide sequences. Minor comments: 5) Fig. 1, 2: For each of the TH and Yellow proteins, the functional domains should be shown and the targets of the guide RNA should be indicated. 6) All of the individuals showing the phenotypes shown in Figs. 3 and 4 appear to have abnormal antennae. Is the effect on the antennae significant? 7) Method: The authors should specify the database used to identify the TH and yellow genes in crickets. 8) line 225 : I could not understand the meaning of this sentence. 9) line 230-231: In the results section, there appears to be no description of the body defect due to TH gene knockout mentioned here. Also, what specific data is the statement that it is essential for "growth and development" based on? At least lethality does not necessarily mean that it is involved in growth and development. 10) Table1: This table is difficult to comprehend. What do the numbers in "gonadal mosaics" mean? Does it mean the efficiency of introducing mutations into the germplasm? It is also unclear what the numbers in Number of mutations mean. An explanation of how these numbers were calculated is needed. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-22-04580R1CRISPR/Cas9-Mediated Genomic Knock out of Tyrosine Hydroxylase and Yellow genes in Cricket Gryllus bimaculatusPLOS ONE Dear Dr. He, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Your revised manuscript was reviewed by the three reviewers who originally reviewed the original manuscript. Two of them still raised some concerns. Please revise it according to their suggestions. In this regard, a previous paper describing genome editing in cricket must be cited as one of them suggested. In addition, the scope of the manuscript should be shifted as they suggested. Furthermore, there are some inconsistencies in data (Figures and Tables). Please check them carefully and provide raw data for qPCR and others so that the reviewers can re-analyze them independently. Please submit your revised manuscript by Oct 15 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Hodaka Fujii, M.D., Ph.D. Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: No Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have addressed most of the criticisms and performed several suggested experiments to address critical points. Although the authors responded well to the reviewers' comments several minor changes are still required. I don’t know whether the journal accepted the style, but it makes it hard to read the figure legends embedded in the result section. The figure legends should be in a different section. In Figure 1, please include UTRs and CDS to understand gene structures. Line 216 and Figure 3. The author performed in vitro cleavage assay to evaluate gRNA efficiency. Could you please specify the size (length) of the target amplicon? Then also, please show the size of the cleaved amplicon. Line 93 and Figure 1. Please organize the accession number of protein sequences in insects that are used in the phylogenetic analysis in a supplemental text. Line 181. Please describe what tissues were used, sample number, and biological replicates leading to the statistical changes by the qPCR. Reviewer #2: (No Response) Reviewer #3: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-22-04580R2CRISPR/Cas9-Mediated Genomic Knock out of Tyrosine Hydroxylase and Yellow genes in Cricket Gryllus bimaculatusPLOS ONE Dear Dr. He, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Your manuscript was reviewed by the three referees who had reviewed the original and revised manuscripts. As some reviewers pointed out, your manuscript needs an additional revision. Please revise your manuscript according to their suggestions. Especially,
Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Hodaka Fujii, M.D., Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Although the authors responded well to the reviewers’comments, several minor changes are still required. In Table 1, Please describe the differences of the nucleotide shown capital and small letters. Please match the decimal place that used in the main text and table. In Figure 1, UTRs should be UTR. Reviewer #2: The authors reworked Figures properly and modified Tables with appropriate values. The authors cited new references and added discussion, but the research focus of this manuscript was still to establish and optimize the genome editing strategy using Cas9 protein, and the authors did not shift to the research focus to pigmentation process. The genome editing strategy using Cas9 protein were already established as I mentioned through the review comments, so the novelty of this manuscript is none if the authors insist to publish the manuscript as methods paper. In addition, I recommended to add discussion about the Ddc gene expression in previous review comment, but was not enough discussed. I strongly recommend all authors must read and check all the text, figures and tables, because there are lots of careless mistakes in this manuscript. Major comments: 1. The authors modified figure 3 and figure 9. In these figures, the authors showed that GGC sequences just adjacent to 5' side of sgRNA in yellow-y gene are the PAM sequences, but could be incorrect. PAM sequences must be NGG for Cas9 and locate just adjacent to 3' side of sgRNA, thus, I think that AGG sequences shown in figure 9D could be the PAM sequences. In figure 3D, I was confused that double peaks were appeared far from PAM sequences, as I pointed out in previous review comments. If the AGG was correct PAM sequences, double peaks in figure 3D were very close to PAM sequences and that is reasonable. The authors have to confirm the correct PAM sequences and should rewrite results and discussion and rework many figures, based on the position of PAM sequences. 2. To answer my previous comment, the authors discuss about the decreased expression of Ddc in TH knock out crickets in line 332-333, citing the genetic loci of Ddc and TH in Tenebrio molitor. However, in Gryllus bimaculatus, TH and Ddc are found in different scaffolds, thus the situation is completely different to the Tenebrio molitor. The authors should show the evidence why Ddc was decreased in TH knock out crickets or add the appropriate discussion. Minor points Line 5 "knoc kout" should be "knock out" in the short title . Materials and Methods Some values are described with hyphen and others are without. Authors should unify their description without hyphens. Line 202 Authors explained about gene structure of TH, but did not about yellow-y, although the figure 1 contains both TH and yellow-y. Line 237 Fig. 7 should be Fig. 8. Line 248 wild-type should be WT. Line 263-264 Fig. 11A should be Fig. 11A,B and Fig. 11B should be Fig. 11C. Line 480 larval instar should be nymphal instar. Line 495-496 yellow-y should be in italic. Reviewer #3: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
PONE-D-22-04580R3CRISPR/Cas9-Mediated Genomic Knock out of Tyrosine Hydroxylase and Yellow genes in Cricket Gryllus bimaculatusPLOS ONE Dear Dr. He, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. One of the reviewers pointed out some incorrectness in the revised manuscript. Please check and revise them, if necessary. In addition, it comes to our notice that some sentences are significantly or even completely identical to those of other publications. Examples are: Lines 61 - 63 Lines 71 - 79 Lines 107 - 108 Lines 112 - 115 Lines 121 - 122 Lines 124 - 127 Lines 128 - 129 Lines 159 - 161 Lines 181 - 183 Lines 184 - 193 Lines 264 - 268 Lines 277 - 290 Lines 291 - 293 Lines 314 - 315 Lines 321 - 322 Please rephrase them to avoid potential suspicion of plagiarism, which is not accepted. iThenticate or similar tool should be used to confirm that there are no sentences identical to those of other publications. Please submit your revised manuscript by Apr 14 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Hodaka Fujii, M.D., Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: All the points raised in the previous version of MS have been addressed by the authors. This reviewer satisfied with the revisions. Reviewer #2: The authors changed the research focus from the establishment of genome editing strategy to the functional analyses of pigmentation gene. The authors responded reviewers' comments, however, there are still incorrect in supplementary figure, and the authors need to further rework the figure. Major comment I pointed out the mistakes of the PAM sequences of yellow-y in my previous comment, and the authors rework the figure 3. However, the PAM sequences of yellow-y indicated in Supplementary Fig 2 were still incorrect. The authors should rework them. Minor comments line 205-206:The authors should insert space before the "bp". line 236 "The legs and wings of the adult is" should be "The legs and wings of the adult are". ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 4 |
|
CRISPR/Cas9-Mediated Genomic Knock out of Tyrosine Hydroxylase and Yellow genes in Cricket Gryllus bimaculatus PONE-D-22-04580R4 Dear Dr. He, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Hodaka Fujii, M.D., Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: All the points raised in the previous version of MS have been addressed by the authors. Reviewer #2: The authors reworked Supplementary Figure 2 and edited some sentences according to the reviewers' comments. The authors rewrote some sentences according to the editors' comments, but the authors need to edit out some minor editing errors. Minor comments In these sentences, insert a space before the brackets. line 75: synthesized(Andersen, 2012). line 265 rate(Bassett et al., 2013; Bi et al., 2016). line 287 development(Gorman and Arakane, 2010). These grammatical careless errors can be prevented by having all co-authors read the manuscript. Authors must make every effort to reduce grammatical errors before submission. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-22-04580R4 CRISPR/Cas9-Mediated Genomic Knock out of Tyrosine Hydroxylase and Yellow Genes in Cricket Gryllus bimaculatus Dear Dr. He: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Hodaka Fujii Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .